• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

The World Market for Molecular Diagnostics Update (Microbiology, Histology, Blood Screening, Prenatal, Coagulation, Inherited Diseases, Tissue Typing, Cancer Markers, Pharmacodiagnostics, CTCs)

$995.00 – $1,990.00

Clear
SKU: KLI5181507 Category: Diagnostics Market Research Pages: 80
  • Description
  • Table of Contents
  • Latest reports

Description

Molecular diagnostics is becoming a dominant platform in clinical medicine and represents one of the fastest growing segments of the diagnostics market. Many molecular tests are CE Marked and FDA-cleared and many more are in development.  However many more unique tests have been launched as test services, especially for cancer management and infectious disease epidemiology.

In light of the amount of activity in test development and regulatory and reimbursement challenges in 2013, Kalorama Information presents this updated review of molecular diagnostics with an emphasis on the last six months of 2013: July – December.   This report highlights trends and developments that portent the evolution of molecular tests and technologies.  The ensemble of consumer demand, technological advances and market forces create a dynamic, energetic and fast-moving environment for new tests and companies.

Though focused on the developments of the last six months, coverage is substantial.  As part of its coverage, this report provides, current market size and forecasts for Molecular Diagnostic Segments, including:

-Microbiology
-Histology
-Blood Screening
-Prenatal
-Coagulation
-Inherited Diseases
-Tissue Typing
-Cancer Markers
-Pharmacodiagnostics
– CTCs

The report provides breakout of key market segments for molecular diagnostic markets in world regions, including developed nations and emerging nations.     In addition the following important trend information is also provided:

-Selected Sequencing-Based Innovations July-December 2013
-Selected Molecular Diagnostics Collaborations, July-December 2013
-Selected Molecular Diagnostics Licensing Agreements, July-December 2013
-Selected Molecular Diagnostics Distribution Agreements, July-December 2013
-Regulatory and Reimbursement Update
-Molecular Test Revenues of The Top Companies, 2012-2013

Market analysis in this report covers world markets for in vitro diagnostics, however the reader will find a bias toward the developed areas of the globe — North America and Western Europe.  However public health and infectious disease are a growing global problem and where possible the report covers IVD products related to the globalization of diseases. The information presented in this report is derived primarily from company reports and other publicly available information published by government, and medical organizations.

Table of Contents

CHAPTER ONE: MARKET OVERVIEW

Background

Scope and Methodology

Size And Growth Of The Market, Worldwide

Regulatory and Reimbursement Update

Company Moves

Top Suppliers and Niche players

Test Services Continue to Expand

Point of View

CHAPTER TWO: SEQUENCING MOVES TO THE CLINIC

Background

Cancer gets more personal

Pathogen sequencing

CHAPTER THREE: THE MARKET FOR BLOOD-BASED MARKERS IN CANCER

Background

Blood-based analyses

Circulating Tumor Cells

CHAPTER FOUR: THE MARKET FOR MOLECULAR ASSAYS IN HEMATOLOGY

Background

CHAPTER FIVE: THE MARKET FOR MOLECULAR ASSAYS IN COAGULATION AND CARDIAC CARE

Background

Coagulation Market Analysis

CHAPTER SIX: THE MARKET FOR MOLECULAR ASSAYS IN HISTOPATHOLOGY/CYTOLOGY

Background

Molecular Histology

Market Analysis

HPV Testing

CHAPTER SEVEN: THE MARKET FOR MOLECULAR ASSAYS IN MICROBIOLOGY/VIROLOGY

Overview

HIV/AIDS

Hepatitis

Sexually Transmitted Diseases

Hospital Acquired Infections

Respiratory Tract Infections

Tuberculosis

Blood Culture

Miscellaneous

Mass Spectrometry

CHAPTER EIGHT: THE MARKET FOR MOLECULAR ASSAYS IN BLOOD TRANSFUSION SCREENING

Background

Blood Pathogen Screening

Blood Typing

CHAPTER NINE: THE MARKET FOR MOLECULAR ASSAYS IN BLOOD TRANSFUSION SCREENING

Background

Blood Pathogen Screening

Blood Typing

CHAPTER TEN: The Market For Molecular Assays For Inherited Diseases

Market Analysis

CHAPTER ELEVEN: The Market For Molecular Assays In Organ Transplant

Management

Market Analysis

CHAPTER TWELVE: The Market For Molecular Assays

In Prenatal And Neonatal Testing

Market Analysis

CHAPTER THIRTEEN: Forecast: An Eye For The Next Six Months

– January To June 2014

Market Analysis

CHAPTER ONE: MARKET OVERVIEW

Table 1-1: Exchange Rate Fluctuations, 2009-2013

Table 1-2: Worldwide Molecular Test Sales, 2012-2013, by Test Segment (Growth Rates in

Molecular Diagnostics Compared (Microbiology, Histology, Blood Screening, Prenatal,

Coagulation, Inherited Diseases, Tissue Typing, Cancer Markers, Pharmacodiagnostics, CTCs)

Table 1-3: Worldwide Molecular Test Sales, 2012-2013, By Geography (North America, Western Europe, Japan, China, Latin America, ROW)

Table 1-3: Worldwide Molecular Test Sales, 2012-2013, By Geography (North America, Western Europe, Japan, China, Latin America, ROW)

Table 1-4: Selected Advanced Test Innovations, July –December 2013

Table 1-5: Selected Company Purchases And Joint Ventures, July-December 2013

Table 1-6: Selected collaborations, July-December 2013

Table 1-7: Selected licensing agreements, July-December 2013

Table 1-8: Selected distribution agreements, July-December 2013

Table 1-9: Molecular Test Revenues of The Top Companies, 2012-2013

Table 1-9: Molecular Test Revenues of The Top Companies, 2012 Vs. 2013

Table 1-10: Selected Molecular Test Services, Sales 2012-2013

Table 1-11: Selected Molecular Test Services, July-December 2013

CHAPTER TWO: SEQUENCING MOVES TO THE CLINIC

Table 2-1: Major Sequencing Platforms

Table 2-2: Selected Sequencing-Based Innovations July-December 2013

CHAPTER THREE: THE MARKET FOR BLOOD-BASED MARKERS IN CANCER

Table 3-1: Selected Innovation In Blood-Based Cancer Tests, July-December 2013

Table 3-2: Selected Non-Invasive Molecular Cancer Tests In Development, July-December 2013

Table 3-3: Selected Innovations In Circulating Tumor Cell Testing, July-December 2013

CHAPTER FOUR: THE MARKET FOR MOLECULAR ASSAYS IN HEMATOLOGY

Table 4-1: Selected Innovations In Molecular Hematological Tests, July-December 2013

CHAPTER FIVE: THE MARKET FOR MOLECULAR ASSAYS IN COAGULATION AND CARDIAC CARE

Table 5-1: Selected Tests For Coagulation And Cardiac Disease Molecular Markers July- December 2013

CHAPTER SIX: THE MARKET FOR MOLECULAR ASSAYS IN HISTOPATHOLOGY/CYTOLOGY

Table 6-1: Worldwide Molecular Histology/Cytology Sales, 2012-2013

Table 6-2: Selected Molecular Histology Innovations, July-December 2013

Table 6-3: Selected Innovations In Molecular Tissue Sample Preparation, July – December 2013

Table 6-4: Selected Innovations In HPV Testing, July –December 2013

CHAPTER SEVEN: THE MARKET FOR MOLECULAR ASSAYS IN MICROBIOLOGY/VIROLOGY

Table 7-1: Molecular Test Sales, Microbiolog/Virology, 2012-2013

Table 7-2: Selected Hepatitis Test Innovations, July-December 2013

Table 7-3: Selected Innovations In Molecular STD Testing, July-December 2013

Table 7-4: Selected Molecular HAI Test Innovations, July-December 2013

Table 7-5: Selected Respiratory Tract Test Innovations, July-December 2013

Table 7-6: Selected Microbiology Innovations, July-December 2013

CHAPTER NINE: THE MARKET FOR MOLECULAR ASSAYS FOR INHERITED DISEASES

Table 9-1: Selected Innovations In Molecular Tests For Inherited Diseases, July – December 2013

CHAPTER ELEVEN: The Market For Molecular Assays In Organ Transplant Management

Table 11-1: Selected Innovations In Prenatal Testing, July-December 2013

 

    Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025
    June 12, 2025
    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025

Related products

  • Placeholder image

    The U.S. Market for Over-the-Counter Pediatric Medication and Healthcare Products

    $3,000.00 – $6,000.00
  • Placeholder image

    Cell-Based Diagnostics: Technology, Applications, and Markets

    $3,500.00 – $7,000.00
  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats Volume I: Prion Disease

    $1,496.00 – $2,992.00
  • Placeholder image

    U.S. Market for Over-the-Counter Diagnostics: Product Sales and Consumer Survey, The

    $4,995.00 – $9,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
The World Market for Infusion Pumps: Forecasts to 2018 (Large Volume Pumps,...The Worldwide Market for Respiratory Devices: Forecasts to 2018 (Inhalers, Nebulizers,...
Scroll to top